A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
Conditions
KRAS P.G12C · Pancreatic Cancer · Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
The First Affiliated Hospital of Sun, Yat-sen University, Guangzhou, Guangdong, China
Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
Hunan Provincial People's Hospital, Changsha, Hunan, China
Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
The First Hospital of China Medical University, Shenyang, Liaoning, China
Shandong Cancer Hospital, Jinan, Shandong, China
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Shanghai Changhai Hospital, Shanghai, Shanghai Municipality, China
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Tianjin Medical University Cancer Institute＆Hospital, Tianjin, Tianjin Municipality, China
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Study leads
Shanghai Allist Pharmaceuticals
Study Director
Shanghai Allist Pharmaceuticals Co.,Ltd.